What the FDA labels say about taking them together
Flibanserin and trandolapril/verapamil
Trandolapril/verapamil's FDA label of January 29, 2026 names flibanserin in its contraindications section; the flibanserin label PlainMeds reads does not name trandolapril/verapamil. The trandolapril/verapamil label: “Flibanserin Verapamil component Use of a moderate CYP3A4 inhibitor such as verapamil with flibanserin significantly increases flibanserin concentrations, which can lead to severe hypotension and syncope.”
Check it at the source: the flibanserin FDA label on DailyMed (effective December 22, 2025, Sprout Pharmaceuticals, Inc.); the trandolapril/verapamil FDA label on DailyMed (effective January 29, 2026, Glenmark Pharmaceuticals Inc., USA).
What does the flibanserin label say about trandolapril/verapamil?
Flibanserin's label (effective December 22, 2025) does not name trandolapril/verapamil in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (ADDYI), Sprout Pharmaceuticals, Inc., effective December 22, 2025 (SPL set 3819daf3-e935-2c53-c527-e1d57922f394), via openFDA; the full label on DailyMed
What does the trandolapril/verapamil label say about flibanserin?
Trandolapril/verapamil label, contraindicationsPatients taking flibanserin (see PRECAUTIONS - Drug Interactions ).
Trandolapril/verapamil label, drug interactionsFlibanserin Verapamil component Use of a moderate CYP3A4 inhibitor such as verapamil with flibanserin significantly increases flibanserin concentrations, which can lead to severe hypotension and syncope.
Source: FDA drug label (Trandolapril and Verapamil Hydrochloride), Glenmark Pharmaceuticals Inc., USA, effective January 29, 2026 (SPL set 39bad727-af4c-4d20-933b-7f287e88099a), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Flibanserin | Trandolapril/verapamil | |
|---|---|---|
| Labeled for | n/a | High blood pressure |
| Boxed warning | Yes | Yes |
| Pharmacy cost (NADAC) | n/a | n/a |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once